588 related articles for article (PubMed ID: 24160951)
1. [Helicobacter pylori-related diseases].
Gisbert JP
Gastroenterol Hepatol; 2013 Oct; 36 Suppl 2():39-50. PubMed ID: 24160951
[TBL] [Abstract][Full Text] [Related]
2. [Helicobacter pylori-related diseases].
Gisbert JP
Gastroenterol Hepatol; 2012 Sep; 35 Suppl 1():12-25. PubMed ID: 23018004
[TBL] [Abstract][Full Text] [Related]
3. [Helicobacter pylori-related diseases: dyspepsia, ulcers and gastric cancer].
Gisbert JP
Gastroenterol Hepatol; 2011 Oct; 34 Suppl 2():15-26. PubMed ID: 22330153
[TBL] [Abstract][Full Text] [Related]
4. [Diseases linked to Helicobacter pylori infection].
Gisbert JP
Gastroenterol Hepatol; 2014 Sep; 37 Suppl 3():40-52. PubMed ID: 25294265
[TBL] [Abstract][Full Text] [Related]
5. [Helicobacter pylori-associated diseases].
Gisbert JP
Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():39-48. PubMed ID: 26520195
[TBL] [Abstract][Full Text] [Related]
6. [Helicobacter pylori-related diseases: dyspepsia, ulcer and gastric cancer].
Gisbert JP
Gastroenterol Hepatol; 2008 Oct; 31 Suppl 4():18-28. PubMed ID: 19434862
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori-related diseases.
Gisbert JP
Gastroenterol Hepatol; 2016 Sep; 39 Suppl 1():36-46. PubMed ID: 27888863
[TBL] [Abstract][Full Text] [Related]
8. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori.
Malfertheiner P; Selgrad M
Curr Opin Gastroenterol; 2014 Nov; 30(6):589-95. PubMed ID: 25268839
[TBL] [Abstract][Full Text] [Related]
10. [Helicobacter pylori - 2012].
Buzás GM
Orv Hetil; 2012 Sep; 153(36):1407-18. PubMed ID: 22951408
[TBL] [Abstract][Full Text] [Related]
11. 'Rescue' therapies for the management of Helicobacter pylori infection.
Di Mario F; Cavallaro LG; Scarpignato C
Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
[TBL] [Abstract][Full Text] [Related]
12. Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication.
Schrauwen RW; Janssen MJ; de Boer WA
Neth J Med; 2009 Mar; 67(3):96-101. PubMed ID: 19307680
[TBL] [Abstract][Full Text] [Related]
13. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.
Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A
Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503
[TBL] [Abstract][Full Text] [Related]
14. Ten-day Quadruple therapy comprising proton-pump inhibitor, bismuth, tetracycline, and levofloxacin achieves a high eradication rate for Helicobacter pylori infection after failure of sequential therapy.
Hsu PI; Chen WC; Tsay FW; Shih CA; Kao SS; Wang HM; Yu HC; Lai KH; Tseng HH; Peng NJ; Chen A; Kuo CH; Wu DC;
Helicobacter; 2014 Feb; 19(1):74-9. PubMed ID: 24033865
[TBL] [Abstract][Full Text] [Related]
15. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori eradication therapy.
Suzuki H; Nishizawa T; Hibi T
Future Microbiol; 2010 Apr; 5(4):639-48. PubMed ID: 20353303
[TBL] [Abstract][Full Text] [Related]
17. Indications for treatment of Helicobacter pylori infection: a systematic overview.
Veldhuyzen van Zanten SJ; Sherman PM
CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
[TBL] [Abstract][Full Text] [Related]
18. [Helicobacter pylori and digestive hemorrhage due to duodenal ulcer: the prevalence of the infection, the efficacy of 3 triple therapies and the role of eradication in preventing a hemorrhagic recurrence].
Gisbert JP; Boixeda D; Aller R; de la Serna C; Sanz E; Martín de Argila C; Abraira V; García Plaza A
Med Clin (Barc); 1999 Feb; 112(5):161-5. PubMed ID: 10091208
[TBL] [Abstract][Full Text] [Related]
19. Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication.
Di Caro S; Franceschi F; Mariani A; Thompson F; Raimondo D; Masci E; Testoni A; La Rocca E; Gasbarrini A
Dig Liver Dis; 2009 Jul; 41(7):480-5. PubMed ID: 18974025
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori: beyond peptic ulcer disease.
Wisniewski RM; Peura DA
Gastroenterologist; 1997 Dec; 5(4):295-305. PubMed ID: 9436005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
